Filed Pursuant to Rule 424(b)(5)
Registration No. 333-257802
PROSPECTUS SUPPLEMENT
(To Prospectus dated August 10, 2021)
Up to $100,000,000 of Shares of
Common Stock
On September 2, 2021, we entered into a sales agreement, or, as may be amended from time to time, the sales agreement, with Robert W. Baird & Co. Incorporated, BMO Capital Markets Corp., BTIG, LLC, Citigroup Global Markets Inc., JMP Securities LLC, KeyBanc Capital Markets Inc. and Morgan Stanley & Co. LLC, each an agent and, collectively, the agents, relating to shares of our common stock, $0.01 par value per share, or our common stock, offered by this prospectus supplement and the accompanying prospectus pursuant to a continuous offering program. In accordance with the terms of the sales agreement, we may from time to time offer and sell shares of our common stock having an aggregate gross sales price of up to $100,000,000 through the agents, as our sales agents, or directly to the agents, acting as principals, pursuant to this prospectus supplement and the accompanying prospectus.
Sales of shares of our common stock, if any, under this prospectus supplement and the accompanying prospectus may be made in sales deemed to be “at the market” offerings as defined in Rule 415 under the Securities Act of 1933, as amended, or the Securities Act, including (1) by means of ordinary brokers’ transactions on the Nasdaq Stock Market LLC, or the Nasdaq, at market prices prevailing at the time of sale, in negotiated transactions or as otherwise agreed by us, the applicable agent and the applicable investor, (2) or through any market maker or (3) on or through any other national securities exchange or facility thereof, trading facility of a securities association or national securities exchange, alternative trading system, electronic communication network or other similar market venue.
Each agent will receive from us a commission that will not exceed, but may be lower than, 2.0% of the gross sales price of shares of our common stock sold through it as our sales agent. Under the terms of the sales agreement, we may also sell shares of our common stock to each of the agents, as principal, at a price agreed upon at the time of sale. In connection with the sale of shares of our common stock on our behalf, the applicable agent may be deemed to be an “underwriter” within the meaning of the Securities Act, and the compensation of the applicable agent may be deemed to be underwriting discounts or commissions. If we sell shares of our common stock to any agent as principal, we will enter into a separate terms agreement with the agent, setting forth the terms of such transaction, and we will describe the agreement in a separate prospectus supplement or pricing supplement.
The agents are not required to sell any specific number or dollar amount of shares of our common stock but will use their commercially reasonable efforts as our sales agents and subject to the terms of the sales agreement. The shares of our common stock offered and sold through the agents, as our sales agents, pursuant to the sales agreement, will be offered and sold through only one agent on any given day.
The offering of shares of our common stock pursuant to the sales agreement will terminate upon the earlier of (1) the sale of shares of our common stock subject to the sales agreement having an aggregate gross sales price of $100,000,000 and (2) the termination of the sales agreement by us or the agents.
Our common stock is listed on the Nasdaq under the symbol “INDT.” On September 1, 2021, the last reported sale price of our common stock on the Nasdaq was $70.10 per share.
We are organized and conduct our operations to qualify as a real estate investment trust, or REIT, for federal income tax purposes. To assist us in complying with certain federal income tax requirements applicable to REITs, among other purposes, our charter contains certain restrictions relating to the ownership and transfer of our capital stock, including ownership limits of 5.5% in value or in number of shares (whichever is more restrictive) of the outstanding shares of our common stock and 5.5% in value of the aggregate of all classes or series of our capital stock. See the section entitled “Description of Capital Stock — Common Stock — Restrictions on Ownership and Transfer” in the accompanying prospectus for a detailed description of the ownership and transfer restrictions applicable to our common stock.
Investing in shares of our common stock involves risks. See “Risk Factors” beginning on page S-2 of this prospectus supplement.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus to which it relates is truthful or complete. Any representation to the contrary is a criminal offense.
| Baird | | | BMO Capital Markets | | | BTIG | | | Citigroup | |
| JMP Securities | | | KeyBanc Capital Markets | | | Morgan Stanley | | | | |
The date of this prospectus supplement is September 2, 2021.